InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the detailed record of transactions filed by Chang Michael L., Directeur Médical. Insider active across 2 companies, notably Nutex Health, Inc.. Aggregated, 3 filings have been recorded. History available since 1 March 2025. The latest transaction was disclosed on 10 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Michael L. Chang is the Chief Medical Officer at Nutex Health, Inc. In this role, he is responsible for the medical strategy and innovation within the company. Chang plays a key role in developing health solutions aimed at improving patient care.